Amrutanjan Health Care Q4 FY26 Results Preview: FMCG Sales Outlook

Amrutanjan Health Care Q4 FY26 results date is all set to be announced soon and most investors are awaiting it. Professionals are expecting an increase in revenue due to higher sales and a significant rise in PAT. Amrutanjan Health Care was listed on the National Stock Exchange (NSE) on 02-Jan-2015. Amrutanjan Health Care share has its face value of 1 per share, and its NSE symbol is AMRUTANJAN. The company operates in the Healthcare sector and primarily belongs to the Pharmaceuticals industry.

Amrutanjan Health Care Q4 Results 2026 Preview

• Amrutanjan Health Care Q4 FY26 revenue is expected to be around Stable Performance, representing a 7-10% YoY increase compared to the same quarter last year.
• Profit After Tax, or PAT, is projected to rise 8-12% YoY.
• EBITDA to rise 8.50%.
• Amrutanjan Health Care is expected to show Stable Performance in its revenue. 

Click and Sign Up to Get Live Updates on Q4 Results

Amrutanjan Health Care Share Performance

• Over the past six months, Amrutanjan Health Care share price has 17% by 7-10% to 560.25.
• Moreover, over the past year, the stock has 29% by Up
• Despite this weak short-term performance, Amrutanjan Health Care stock has delivered a financially sound 140% return over the past 5 years.
• As of today, 11-03-2026, the Amrutanjan Health Care share price is trading at 560.25 per share.

Key Factors to Watch for Amrutanjan Health Care Q4 Results FY26

• Revenue Growth & Segment Performance – Focus on topline growth in the Pharmaceuticals industry within the Healthcare sector.
• Occupancy Levels & Seat Expansion – Monitor operational expansion and capacity utilisation trends.
• Profitability & Margin Trends – Track EBITDA and PAT margins to evaluate cost control and operating efficiency.
• Order Book & New Client Wins – Watch for updates on new contracts, partnerships, and long-term deals.
• Balance Sheet & Cash Flow Position – Review debt levels, working capital management, and operating cash flows for financial stability.

About Amrutanjan Health Care

Amrutanjan Health Care specializes in pain management products such as balms, gels, and healthcare beverages. The company serves both Indian and international markets, maintaining a strong presence in the over-the-counter healthcare segment with its trusted consumer brands.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Final Thoughts

Amrutanjan Health Care is gear up to announce its Q4 FY26 results. Analysts expect 7-10% revenue growth, a 8-12% rise in PAT, and a 8.50% rise in EBITDA. Amrutanjan Health Care focuses on revenue growth from order execution, margin improvement, a strong order book, and management.

Stay informed with Univest blogs to get real-time updates on Amrutanjan Health Care Q4 results FY26. 

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Recent Articles

Alkem Laboratories Q4 FY26 Results: Earnings Expectations

Allied Blenders Q4 FY26 Results: Sales Growth Expectations

Akzo Nobel India Q4 FY26 Results: Revenue and Profit Outlook

Aditya Birla Lifestyle Brands Q4 FY26 Results: Revenue Outlook

Aditya Birla Fashion Q4 FY26 Results: Sales Growth Expectations

Aditya Birla Capital Q4 FY26 Results: Revenue and Earnings Outlook